Cell-Free DNA Liquid Biopsies for Precision Cardiovascular Medicine
Fördersumme: € 999.285
Predicting the evolution of relapse in Wilms tumour using drug sensitivity profiling and liquid biopsies
Fördersumme: € 999.538
Personalized risk assessment for embryonal tumor predisposition
Fördersumme: € 999.003
Engineering synthetic enhancers and gene circuits to understand and overcome cancer therapy resistance
Dauer: 48 Monate, Fördersumme: € 899.099
Sounds of Silence: Codons and Chaperones in the Protein Folding Concert
Dauer: 48 Monate, Fördersumme: € 899.921
Precision medicine for breast cancer: multi-omics towards predicting complete remission and avoiding surgery
Dauer: 48 Monate, Fördersumme: € 899.630